Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1610-0387.2008.06882.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Celebrating the 40th Anniversary of the American Glaucoma Society: Yesterday, Today, and Tomorrow.
Ophthalmol Glaucoma
January 2025
Oklahoma City, Oklahoma.
[Angiology yesterday and today: vascular sonography and catheter intervention].
Dtsch Med Wochenschr
December 2024
The specialist in angiology was introduced into the discipline of internal medicine in 1992. In the previous decades, the technical methods in angiology were still very limited. However, duplex sonography and endovascular catheter interventions then revolutionized the diagnostic and therapeutic spectrum.
View Article and Find Full Text PDFA Road Map to Hepatitis C Elimination: Yesterday, Today, and Tomorrow.
Open Forum Infect Dis
November 2024
Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
There are an estimated 3.5 million people with hepatitis C virus (HCV) infection in the United States, resulting in 15 000 HCV-related deaths in 2019 and approximately $7 billion annually in healthcare costs. Although the United States had experienced declining incidence, since 2010 hepatitis C infections have rebounded.
View Article and Find Full Text PDFWhat Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow.
Int J Mol Sci
September 2024
Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Article Synopsis
- * The exact cause of peripartum cardiomyopathy is unclear, although factors like age, lifestyle, and genetics may play a role; recent theories suggest that an abnormal form of prolactin may contribute to the heart damage.
- * Ongoing research explores treatments like bromocriptine, a drug that inhibits prolactin, and highlights the importance of safe medication use during pregnancy and breastfeeding, particularly to protect both mothers and their babies.
The Systematics and Phylogeny of Myxomycetes: Yesterday, Today, and Tomorrow.
Dokl Biol Sci
December 2024
Komarov Botanical Institute, Russian Academy of Sciences, 197376, St. Petersburg, Russia.
Myxomycetes are amoeboid fungus-like organisms (Amoebozoa) with a unique life cycle characterized by a great morphological diversity of fruiting bodies. Due to the similarity of these structures to the fruiting bodies of some representatives of Ascomycota and Basidiomycota, myxomycetes have been classified as fungi since the first known scientific description in 1654. Only in the 19th century, when their life cycle was studied, did the difference of this group from fungi become clear.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!